Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To examine Nogo-B in liver tissues and plasma of patients with liver cirrhosis and associate them with various clinical parameters.
Materials And Methods: Nogo-B protein expression was examined by immunohistochemistry in 24 human fibrotic/cirrhotic liver specimens and 10 healthy controls. We determined plasma Nogo-B levels by enzyme-linked immunosorbent assay in 301 patients with liver cirrhosis and 153 healthy controls, and then analyzed various clinical parameters.
Results: Nogo-B was mainly expressed in nonparenchymal cells in the liver and was marked increased in liver with significant fibrosis/cirrhosis compared to controls. Moreover, Metavir F4 showed a higher level of expression than F2. Plasma Nogo-B levels were significantly higher in cirrhotic patients than in healthy controls and were the highest in Child-Pugh class C patients. Plasma Nogo-B levels were positively correlated with Child-Pugh scores. However, there was no relationship between plasma Nogo-B levels and etiology of liver diseases, ALT, AST, platelet counts, and the severity of esophagogastric varices.
Conclusions: Nogo-B is mainly expressed in hepatic nonparenchymal cells and is present in plasma. Abnormally high plasma levels of Nogo-B are associated with hepatic cirrhosis and Child-Pugh score, but not correlated with the grade of liver inflammation or portal hypertension. Plasma Nogo-B may be a novel surrogate marker to reflect liver function reserve.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438164 | PMC |
| http://dx.doi.org/10.1155/2015/419124 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Progression of NUS1-Associated Parkinson's Disease and the Diagnostic Potential of Plasma NgBR.
CNS Neurosci Ther
July 2025
Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Aims: The study aimed to investigate the role of NUS1 variants in Parkinson's disease (PD) progression and evaluate plasma Nogo-B receptor (NgBR) as a potential biomarker.
Methods: We recruited 228 PD patients, including 38 with NUS1 variants (NUS1-PD) and 190 without (GU-PD), and all underwent at least two follow-up visits. Linear mixed-effects models assessed motor and non-motor symptom progression.
Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia.
Cell Rep
September 2024
Department of Cardiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China. Electronic address:
Article Synopsis
- The study explores the role of Nogo-B in managing cholesterol levels, revealing that its deficiency can enhance both the uptake and excretion of cholesterol in the liver.
- Researchers found that inhibiting Nogo-B activates key proteins and receptors, which helps lower cholesterol levels by improving cholesterol metabolism.
- The findings suggest that targeting Nogo-B could be a potential strategy for reducing cholesterol and atherosclerotic plaques in the body.
Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
Circ Res
April 2024
Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Brain and Mind Research Institute (O.L.M., J.N., L.S., A.M., L.R., S.P., A.B., A.D.L.).
Background: Growing evidence correlated changes in bioactive sphingolipids, particularly S1P (sphingosine-1-phosphate) and ceramides, with coronary artery diseases. Furthermore, specific plasma ceramide species can predict major cardiovascular events. Dysfunction of the endothelium lining lesion-prone areas plays a pivotal role in atherosclerosis.
View Article and Find Full Text PDFNogo-A reduces ceramide de novo biosynthesis to protect from heart failure.
Cardiovasc Res
March 2023
Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065, USA.
Article Synopsis
- The study investigates the role of the sphingolipid ceramide in heart failure, focusing on the protein Nogo-A's impact on sphingolipid metabolism in heart cells under stress.
- It finds that Nogo-A negatively regulates the enzyme SPT, crucial for ceramide production, thereby reducing ceramide accumulation during stress, which could otherwise lead to harmful heart changes.
- Ultimately, the research concludes that Nogo-A helps maintain heart health by preserving important cellular functions, preventing the development of heart failure in stressful conditions.
Association between high serum Nogo-B and hypertension in Chinese Han.
BMC Cardiovasc Disord
June 2022
Department of Cardiology, Dalian Municipal Central Hospital, Dalian, China.
Background: Cellular and animal studies have shown that endoplasmic reticulum protein B (Nogo-B) is associated with hypertension, but that association has not been fully studied in humans. Therefore, the expression levels of Nogo-B were investigated in hypertensive patients.
Methods: The plasma Nogo-B levels of 74 patients with hypertension and 67 non-hypertensive patients were measured by enzyme-linked immunosorbent assay.